2017-2022 mRNA Vaccines & Therapeutics Report on Global and United States Market, Status and Forecast, by Players, Types and Applications


#1282805

116pages

QYResearch

$ 2960

In Stock

This report studies the mRNA Vaccines & Therapeutics market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the mRNA Vaccines & Therapeutics market by product type and applications/end industries.

The global mRNA Vaccines & Therapeutics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of mRNA Vaccines & Therapeutics. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of mRNA Vaccines & Therapeutics in these regions, from 2012 to 2022 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States mRNA Vaccines & Therapeutics market, including Argos Therapeutics, AstraZeneca, Bayer, BioNTech, Boehringer Ingelheim, CRISPR Therapeutics, CureVac, ETheRNA immunotherapies, Ethris, GlaxoSmithKline Vaccines, In-Cell-Art, Intellia Therapeutics, Janssen, Kernal Biologics, MaxCyte, Moderna Therapeutics, Novartis, PhaseRx, Precision NanoSystems, RaNa Therapeutics.

The On the basis of product, the mRNA Vaccines & Therapeutics market is primarily split into
Standardization of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

On the basis on the end users/applications, this report covers
In-house mRNA Manufacturing
Out-sourced mRNA Manufacturing

 

Table of Contents

2017-2022 mRNA Vaccines & Therapeutics Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
2.1.1 Secondary Sources
2.1.2 Primary Sources
1.3 Disclaimer
2 mRNA Vaccines & Therapeutics Market Overview
2.1 mRNA Vaccines & Therapeutics Product Overview
2.2 mRNA Vaccines & Therapeutics Market Segment by Type
2.2.1 Standardization Of Cancer Treatment MRNA Vaccine
2.2.2 Individualized Cancer Treatment MRNA Vaccine
2.2.3 Infectious Disease Treatment MRNA Vaccine
2.2.4 Infection Prevention MRNA Vaccine
2.3 Global mRNA Vaccines & Therapeutics Product Segment by Type
2.3.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth (%) by Types (2012, 2016 and 2022)
2.3.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (%) by Types (2012-2017)
2.3.3 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (%) by Types (2012-2017)
2.3.4 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Type (2012-2017)
2.4 United States mRNA Vaccines & Therapeutics Product Segment by Type
2.4.1 United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth by Types (2012, 2016 and 2022)
2.4.2 United States mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Types (2012-2017)
2.4.3 United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Types (2012-2017)
2.4.4 United States mRNA Vaccines & Therapeutics Price (USD/Unit) by Type (2012-2017)
3 mRNA Vaccines & Therapeutics Application/End Users
3.1 mRNA Vaccines & Therapeutics Segment by Application/End Users
3.1.1 In-house mRNA Manufacturing
3.1.2 Out-sourced mRNA Manufacturing
3.2 Global mRNA Vaccines & Therapeutics Product Segment by Application
3.2.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and CGAR (%) by Applications (2012, 2016 and 2022)
3.2.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (%) by Applications (2012-2017)
3.3 United States mRNA Vaccines & Therapeutics Product Segment by Application
3.3.1 United States mRNA Vaccines & Therapeutics Sales (K Units) and CGAR (%) by Applications (2012, 2016 and 2022)
3.3.2 United States mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (%) by Applications (2012-2017)
4 mRNA Vaccines & Therapeutics Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Market Size and CAGR by Regions (2012, 2016 and 2022)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global mRNA Vaccines & Therapeutics Sales and Revenue by Regions
4.2.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (%) by Regions (2012-2017)
4.2.2 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
4.2.3 Global mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.4 North America mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.5 Europe mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.6 Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.7 South America mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
4.2.8 Middle East and Africa mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.9 United States mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
5 Global mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
5.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Players (2012-2017)
5.2 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Share by Players (2012-2017)
5.3 Global mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players (2012-2017)
5.4 Players mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types
5.5 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
5.5.1 mRNA Vaccines & Therapeutics Market Concentration Rate
5.5.2 Global mRNA Vaccines & Therapeutics Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
6.1 United States mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Players (2012-2017)
6.2 United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Share by Players (2012-2017)
6.3 United States mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players (2012-2017)
6.4 United States mRNA Vaccines & Therapeutics Market Share (%) of Top 3 and Top 5 Players
7 mRNA Vaccines & Therapeutics Players/Manufacturers Profiles and Sales Data
7.1 Argos Therapeutics
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.1.4 Main Business/Business Overview
7.2 AstraZeneca
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Bayer
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.3.4 Main Business/Business Overview
7.4 BioNTech
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Boehringer Ingelheim
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.5.4 Main Business/Business Overview
7.6 CRISPR Therapeutics
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.6.4 Main Business/Business Overview
7.7 CureVac
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.7.4 Main Business/Business Overview
7.8 ETheRNA immunotherapies
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 ETheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Ethris
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.9.4 Main Business/Business Overview
7.10 GlaxoSmithKline Vaccines
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.10.4 Main Business/Business Overview
7.11 In-Cell-Art
7.12 Intellia Therapeutics
7.13 Janssen
7.14 Kernal Biologics
7.15 MaxCyte
7.16 Moderna Therapeutics
7.17 Novartis
7.18 PhaseRx
7.19 Precision NanoSystems
7.20 RaNa Therapeutics
8 mRNA Vaccines & Therapeutics Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 mRNA Vaccines & Therapeutics Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global mRNA Vaccines & Therapeutics Market Forecast
10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue Forecast (2017-2022)
10.1.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
10.1.2 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
10.2 United States mRNA Vaccines & Therapeutics Market Forecast
10.1.1 United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
10.2.2 United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
10.3 Global mRNA Vaccines & Therapeutics Forecast by Regions
10.3.1 North America mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.2 Europe mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.4 South America mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.5 Middle East and Africa mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.4 mRNA Vaccines & Therapeutics Forecast by Type
10.4.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast by Type (2017-2022)
10.4.2 United States mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Forecast by Type (2017-2022)
10.5 mRNA Vaccines & Therapeutics Forecast by Application
10.5.1 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
10.5.2 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
11 Research Findings and Conclusion
 

List of Tables and Figures

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure mRNA Vaccines & Therapeutics Product Picture
Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) Status and Outlook (2012-2022)
Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) Status and Outlook (2012-2022)
Figure Product Picture of Standardization Of Cancer Treatment MRNA Vaccine
Table Major Players of Standardization Of Cancer Treatment MRNA Vaccine
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Sales (K Units) and Growth Rate (%) (2012-2017)
Figure Product Picture of Individualized Cancer Treatment MRNA Vaccine
Table Major Players of Individualized Cancer Treatment MRNA Vaccine
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales (K Units) and Growth Rate (%) (2012-2017)
Figure Product Picture of Infectious Disease Treatment MRNA Vaccine
Table Major Players of Infectious Disease Treatment MRNA Vaccine
Figure Global Infectious Disease Treatment MRNA Vaccine Sales (K Units) and Growth Rate (%) (2012-2017)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012, 2016 and 2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Types (2012-2017)
Table Global mRNA Vaccines & Therapeutics Sales Share (%) by Types (2012-2017)
Figure Global Sales mRNA Vaccines & Therapeutics Market Share (%) by Types (2012-2017)
Figure Global Sales mRNA Vaccines & Therapeutics Market Share (%) by Types in 2016
Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Types (2012-2017)
Table Global mRNA Vaccines & Therapeutics Revenue Share (%) by Types (2012-2017)
Figure Global mRNA Vaccines & Therapeutics Revenue Share (%) by Types (2012-2017)
Figure 2016 Global mRNA Vaccines & Therapeutics Revenue Market Share (%) by Types
Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Types (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012, 2016 and 2022)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Types (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Share (%) by Types (2012-2017)
Figure United States Sales mRNA Vaccines & Therapeutics Market Share (%) by Types (2012-2017)
Figure United States Sales mRNA Vaccines & Therapeutics Market Share (%) by Types in 2016
Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Types (2012-2017)
Table United States mRNA Vaccines & Therapeutics Revenue Share (%) by Types (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Revenue Share (%)by Types (2012-2017)
Figure 2016 United States mRNA Vaccines & Therapeutics Revenue Market Share (%) by Types
Table United States mRNA Vaccines & Therapeutics Price (USD/Unit) by Types (2012-2017)
Figure In-house mRNA Manufacturing Examples
Figure Out-sourced mRNA Manufacturing Examples
Table United States mRNA Vaccines & Therapeutics Sales (K Units) Comparison by Applications (2012-2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Applications (2012-2017)
Table Global mRNA Vaccines & Therapeutics Sales Share (%) by Applications (2012-2017)
Figure Global Sales mRNA Vaccines & Therapeutics Market Share (%) by Applications (2012-2017)
Figure Global Sales mRNA Vaccines & Therapeutics Market Share (%) by Applications in 2016
Table United States mRNA Vaccines & Therapeutics Sales (K Units) Comparison by Applications (2012-2022)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Applications (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Share (%) by Applications (2012-2017)
Figure United States Sales mRNA Vaccines & Therapeutics Market Share (%) by Applications (2012-2017)
Figure United States Sales mRNA Vaccines & Therapeutics Market Share (%) by Applications in 2016
Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) and CAGR Comparison by Regions (2012-2022)
Figure North America mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share (%) by Regions (2012-2017)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global mRNA Vaccines & Therapeutics Sales Market Share (%) by Regions
Figure 2016 United States mRNA Vaccines & Therapeutics Sales Market Share (%) in Global Market
Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
Table Global mRNA Vaccines & Therapeutics Revenue Market Share (%) by Regions (2012-2017)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global mRNA Vaccines & Therapeutics Revenue Market Share (%) by Regions
Table Global mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table North America mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Europe mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table South America mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Middle East and Africa mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) of Key Players (2012-2017)
Table Global mRNA Vaccines & Therapeutics Sales Share (%) by Players (2012-2017)
Figure 2016 Global mRNA Vaccines & Therapeutics Sales Share (%) by Players
Figure 2017 Global mRNA Vaccines & Therapeutics Sales Share (%) by Players
Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Players (2012-2017)
Table Global mRNA Vaccines & Therapeutics Revenue Share (%) by Players (2012-2017)
Table 2016 Global mRNA Vaccines & Therapeutics Revenue Share (%) by Players
Table 2016 Global mRNA Vaccines & Therapeutics Revenue Share (%) by Players
Table Global Market mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players (2012-2017)
Table United States mRNA Vaccines & Therapeutics Top Players Manufacturing Base Distribution and Sales Area
Table United States mRNA Vaccines & Therapeutics Top Players Product Category
Figure Global mRNA Vaccines & Therapeutics Market Share (%) of Top 3 Players
Figure Global mRNA Vaccines & Therapeutics Market Share (%) of Top 5 Players
Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Players (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Market Share (%) by Players (2012-2017)
Figure 2016 United States mRNA Vaccines & Therapeutics Sales Share (%) by Players
Figure 2017 United States mRNA Vaccines & Therapeutics Sales Share (%) by Players
Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Players (2012-2017)
Table United States mRNA Vaccines & Therapeutics Revenue Market Share (%) by Players (2012-2017)
Table 2016 United States mRNA Vaccines & Therapeutics Revenue Share (%) by Players
Table 2016 United States mRNA Vaccines & Therapeutics Revenue Share (%) by Players
Table United States Market mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Market Share (%) of Top 3 Players
Figure United States mRNA Vaccines & Therapeutics Market Share (%) of Top 5 Players
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table Bayer Basic Information List
Table Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table BioNTech Basic Information List
Table BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table CRISPR Therapeutics Basic Information List
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table CureVac Basic Information List
Table CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table ETheRNA immunotherapies Basic Information List
Table ETheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure ETheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure ETheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure ETheRNA immunotherapies mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table Ethris Basic Information List
Table Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table GlaxoSmithKline Vaccines Basic Information List
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Global Market Share (%) (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Revenue Global Market Share (%) (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
Table Major Buyers of mRNA Vaccines & Therapeutics
Table Distributors/Traders List
Figure Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure United States mRNA Vaccines & TherapeuticsmRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global mRNA Vaccines & Therapeutics Sales (Million USD) Forecast by Type (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share (%) Forecast by Type (2017-2022)
Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share (%) Forecast by Type (2017-2022)
Table United States mRNA Vaccines & Therapeutics Sales (Million USD) Forecast by Type (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Market Share (%) Forecast by Type (2017-2022)
Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2017-2022)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Forecast by Application (2017-2022)




2017-2022 @@@@ Report on Global and United States Market, Status and Forecast, by Players, Types and Applications